While it may be dominating the market in terms of sales, some industry observers believe that AncestryDNA has work to do before it can challenge the quality of services offered by its rivals.
For the first time in the consumer genomics industry, AncestryDNA will provide customers with a list of probable ancestors based solely on their microarray data.
Scheller discussed with GenomeWeb why he joined 23andMe after leaving Genentech and his plans for the new therapeutics division.
The consumer genomics firm has created a therapeutics group headed up by former Genentech executive Richard Scheller.
The value of consumer genomics services is increasing as customers seek to discover new cousins and adoptees track down their biological birth parents.
Genentech and 23andMe aim to advance Parkinson's drug research by sequencing the largest number of people to date.
Consumer genomics companies have seen their databases swell with hundreds of thousands of new samples, introduced diverse offerings, and adjusted to new competitors.
Toshiba has the exclusive right to provide genotyping services on the Japonica Array to Japanese universities, hospitals, pharmaceutical companies, and other research organizations.
The FDA's regulation of lab tests and devices used in clincial investigations is impacting federally funded study protocols involving advanced sequencing tests.
For the time being, the company doesn't expect to run into regulatory trouble in the UK.
A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.
A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.
NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.
In Nature this week: epigenetic factors that prevent healthy aging and more.